Display options
Cite
Hagerman PJ, Hagerman R. Fragile X syndrome. Curr Biol. 2021;31(6):R273-R275doi: 10.1016/j.cub.2021.01.043.
Hagerman, P. J., & Hagerman, R. (2021). Fragile X syndrome. Current biology : CB, 31(6), R273-R275. https://doi.org/10.1016/j.cub.2021.01.043
Hagerman, Paul J, and Hagerman, Randi. "Fragile X syndrome." Current biology : CB vol. 31,6 (2021): R273-R275. doi: https://doi.org/10.1016/j.cub.2021.01.043
Hagerman PJ, Hagerman R. Fragile X syndrome. Curr Biol. 2021 Mar 22;31(6):R273-R275. doi: 10.1016/j.cub.2021.01.043. PMID: 33756134.
Copy Download .nbib Format: NLM
Share it on

Curr Biol. 2021 Mar 22;31(6):R273-R275. doi: 10.1016/j.cub.2021.01.043.

Fragile X syndrome.

Current biology : CB

Paul J Hagerman, Randi Hagerman

Affiliations

  1. Department of Biochemistry and Molecular Medicine and UC Davis MIND Institute, University of California, Davis, School of Medicine, One Shields Avenue, Davis, CA 95616, USA. Electronic address: [email protected].
  2. Department of Pediatrics and UC Davis MIND Institute, University of California, Davis, Health System, 2825 50th Street, Sacramento, CA 95817, USA.

PMID: 33756134 DOI: 10.1016/j.cub.2021.01.043

Abstract

Paul Hagerman and Randi Hagerman introduce the X-linked neurodevelopmental disorder Fragile X syndrome (FXS) and discuss what causes this disorder and how it can be treated.

Copyright © 2021 Elsevier Inc. All rights reserved.

Conflict of interest statement

Declaration of interests P.J.H. is a member of the Scientific Advisory Board of NeuCyte Pharmaceuticals, Inc. R.H. is a member of the Scientific and Clinical advisory committee of the National Fragile

Publication Types

Grant support